Barclays’s 1Life Healthcare ONEM Stock Holding History

Barclays’s Portfolio ONEM Stock Details ONEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-3,049,399	Closed	-$51M	–	5530
2022 Q4	$51M	Buy	3,049,399 +1,467,388	+93%	+$24.8M	0.02%	476
2022 Q3	$27.1M	Buy	1,582,011 +1,506,790	+2,003%	+$23.7M	0.03%	510
2022 Q2	$590K	Sell	75,221 -8,227	-10%	-$70.7K	﹤0.01%	2751
2022 Q1	$925K	Buy	+83,448	New	+$935K	﹤0.01%	2477

Barclays's ONEM Position: Q1 2023 in Review

Barclays sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 3,049,399 shares — an estimated $51M sold.

Barclays first reported a position in ONEM in Q1 2022 and held it in 4 quarters. The position peaked at $51M in Q4 2022. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.

Barclays reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
Barclays sold 3,049,399 1Life Healthcare shares in Q1 2023, an estimated $51M.
Barclays first reported a position in 1Life Healthcare in Q1 2022 and held it in 4 quarters.
Barclays's 1Life Healthcare position peaked at $51M in Q4 2022.
0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.

Based on Barclays's 13F filing for Q1 2023, filed 4 May 2023.